Molecular Interactions and Regulation of p53
p53 的分子相互作用和调控
基本信息
- 批准号:7896964
- 负责人:
- 金额:$ 20.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAddressAffinityApoptosisBindingBinding ProteinsBiochemicalBiologicalBiological AssayBromodomainC-terminalCREB-binding proteinCell Cycle ArrestCellsChemicalsChromatinConflict (Psychology)ConfusionDNA DamageDataEP300 geneGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionGenotoxic StressGoalsHTATIP geneHealthHistone AcetylationHistonesHumanHuman BiologyIn VitroIndividualJointsLeadLigandsLysineMDM2 geneMalignant NeoplasmsMediatingMethylationModificationMolecularOutcomePCAF genePhosphorylationPlayPost-Translational Protein ProcessingProtein p53ProteinsRecruitment ActivityRegulationRelianceReportingRoleSiteSpecificityStressStructureTP53 geneTestingTranscriptional ActivationTranscriptional RegulationTumor SuppressionUbiquitinationbasecancer therapydesignhistone modificationhuman CREBBP proteinimprovedin vivoin vivo Modelmouse modelnoveloncoprotein p21outcome forecastoverexpressionp53-binding proteinresponsesenescencesmall moleculetranscription factortumor
项目摘要
Site-specific post-translational modifications of human tumor suppressor p53 induced by stress play an
important role in the activity of p53 as a transcription factor that regulates cell cycle arrest, senescence or
apoptosis. The Iong-term goal of this Project 2, as a part of the PPG, is to seek mechanistic understanding
of the molecular interactions and regulation of p53 in human biology and cancer. While multiple acetylation
and methylation sites in p53 have been reported, specific effects of individual or combined modifications on
p53 activity remain elusive. Preliminary data is presented involving a structure-based functional analysis of
p53 supporting the notion that acetylation-induced p53 activation in response to DNA damage is involved in
co-activator recruitment and subsequent histone acetylation required for target gene transcriptional
activation. Our study specifically supports the notion that p53 recruitment of the co-activator CBP (CREB
binding protein) requires association of the CBP bromodomain with p53 at acetylated lys[353]: a molecular
interaction that is essential for p53-induced transcriptional activation of the cyclin-dependent kinase inhibitor
p21, involved in (31 cell cycle arrest. We hypothesize therefore that distinct modifications of p53 including
lysine acetylation and merhylation have differential effects on p53 functions in cells. We propose a
multifaceted approach to address mechanistic underpinnings of p53 transcriptional activation with the
emphasis on the role of post-translational modifications in p53 activation. The specific aims are (1) to
elucidate molecular basis of these modification mediated molecular interactions of p53 with co-activators,
and to develop small molecule chemical probes with structure-based design to functionally modulate p53
interactions; and (2) to determine the interplay between the co-activators CBP/p300 and p53 C-terminal
domain in transcriptional regulation and tumor suppression of p53 using a variety of biochemical and cell
biological approaches including the establishment of an in vivo model. The emerging results from our
planned studies are expected to yield new mechanistic understanding of post-translational modifications in
p53 function. Given the central role of p53 in cancer, these studies will have important implications for the
prognosis and treatment of human tumors.
应激诱导的人抑癌基因P53的定点翻译后修饰
作为一种转录因子,P53在调节细胞周期停滞、衰老或
细胞凋亡。作为PPG的一部分,这个项目2的长期目标是寻求机械性的理解
P53在人类生物学和癌症中的分子相互作用和调控。而多重乙酰化
和P53的甲基化位点已有报道,单独或联合修饰对P53的特异性影响
P53的活性仍然难以捉摸。提供了初步数据,涉及基于结构的功能分析
P53支持乙酰化诱导P53激活以响应DNA损伤的概念
靶基因转录所需的辅激活子募集和随后的组蛋白乙酰化
激活。我们的研究明确支持P53共激活因子CBP(CREB)的招募
结合蛋白)需要在乙酰化的Lys[353]上将CBP溴域与P53结合:一种分子
P53诱导细胞周期蛋白依赖性激酶抑制因子转录激活所必需的相互作用
P21,参与(31)细胞周期停滞。因此,我们假设P53的不同修改包括
赖氨酸乙酰化和酰化对细胞内P53功能有不同的影响。我们提出了一个
用多方面的方法解决p53转录激活的机制基础
强调翻译后修饰在P53激活中的作用。具体目标是(1)
阐明这些修饰介导的P53与共激活剂分子相互作用的分子基础,
并开发基于结构设计的小分子化学探针来调节P53的功能
相互作用;以及(2)确定共激活子CBP/p300和p53 C-末端之间的相互作用
用多种生化和细胞方法研究p53转录调控和肿瘤抑制的结构域
生物学方法,包括建立体内模型。来自我们的新成果
计划中的研究预计将产生对翻译后修改的新的机械理解
P53功能。鉴于P53在癌症中的核心作用,这些研究将对
人类肿瘤的预后和治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ming-Ming Zhou其他文献
Ming-Ming Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ming-Ming Zhou', 18)}}的其他基金
Transcriptional Mechanism of BRD4 in Solid Tumor
BRD4在实体瘤中的转录机制
- 批准号:
10358485 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Transcriptional Mechanism of BRD4 in Solid Tumor
BRD4在实体瘤中的转录机制
- 批准号:
10089421 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Transcriptional Mechanism of BRD4 in Solid Tumor
BRD4在实体瘤中的转录机制
- 批准号:
9883764 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Transcriptional Mechanism of BRD4 in Solid Tumor
BRD4在实体瘤中的转录机制
- 批准号:
10582673 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Transcriptional Mechanism of BRD4 in Solid Tumor
BRD4在实体瘤中的转录机制
- 批准号:
10025103 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Mechanism of BET Proteins in Th17 Cell Differentiation
BET蛋白在Th17细胞分化中的机制
- 批准号:
9241951 - 财政年份:2016
- 资助金额:
$ 20.86万 - 项目类别:
Chemical Genomics Paradigm for Epigenetic Regulation
表观遗传调控的化学基因组学范式
- 批准号:
7943541 - 财政年份:2009
- 资助金额:
$ 20.86万 - 项目类别:
Chemical Genomics Paradigm for Epigentic Regulation
表观遗传调控的化学基因组学范式
- 批准号:
8608445 - 财政年份:2008
- 资助金额:
$ 20.86万 - 项目类别:
Chemical Genomics Paradigm for Epigenetic Regulation
表观遗传调控的化学基因组学范式
- 批准号:
8332917 - 财政年份:2008
- 资助金额:
$ 20.86万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 20.86万 - 项目类别:
Research Grant














{{item.name}}会员




